Senior Director of Product Management, Oncology Innovations
NateraSalary not specified
- Full Time
- Senior (5 to 8 years)
$180,000 – $220,000Compensation
Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Medical Affairs, Pharmaceutical, Genetics, HealthcareIndustries
Requirements
The ideal candidate must be board-certified in molecular genetic pathology, possess extensive leadership experience in molecular screening and diagnostic testing for cancer, and have a strong background in molecular and cytogenetic methods used for cancer diagnostics, including complete genomic profiling of solid tumors, cell-free tumor DNA analysis, and germline next-generation sequencing. They should have a demonstrable intimate understanding of next-generation sequencing, clinical laboratory practices, and their regulatory oversight, as well as a wide network of connections with key opinion leaders.
Responsibilities
This role involves informing oncology-related product development, conducting patient safety risk assessments and regulatory submissions, guiding medical research in oncology, overseeing clinical diagnostics for companion diagnostics development, supporting interactions with biopharma collaborations in oncology, and participating in medical education in molecular screening and diagnostics for cancer. The individual will also represent Medical Affairs within cross-functional teams and work closely with various departments including Commercial, Business Development, Pharma, R&D, Product Marketing, Regulatory, Bioinformatics, Assay Development, and Quality teams.
Skills
Next-Generation Sequencing
Molecular Screening
Diagnostic Testing
Cancer Diagnostics
Genomic Profiling
Cell-Free Tumor DNA Analysis
Germline Sequencing
Clinical Laboratory Practices
Regulatory Oversight
Medical Education
Risk Assessment
Biopharma Collaborations
Illumina
Supports genomics startups through funding and resources
About Illumina
Illumina focuses on fostering innovation in the genomics industry by supporting startups through its Illumina Accelerator program. This program helps entrepreneurs create, launch, and grow genomics-focused companies by providing funding and resources. The accelerator operates in two main locations: the San Francisco Bay Area and Cambridge, UK. Illumina Accelerator has successfully invested in 68 genomics startups, which have collectively raised over $1 billion in venture capital. What sets Illumina apart from its competitors is its strong partnership with leading venture capital investors and its dedicated focus on the genomics sector. The goal of Illumina is to build a thriving ecosystem for genomics innovation, enabling new companies to emerge and advance the field.
Key Metrics
San Diego, CaliforniaHeadquarters
1998Year Founded
$27.2MTotal Funding
IPOCompany Stage
Venture Capital, BiotechnologyIndustries
5,001-10,000Employees